» Articles » PMID: 10339586

Calcineurin and Vacuolar-type H+-ATPase Modulate Macrophage Effector Functions

Overview
Specialty Science
Date 1999 May 26
PMID 10339586
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

While effector molecules produced by activated macrophages (including nitric oxide, tumor necrosis factor alpha, interleukin 1, etc.) help to eliminate pathogens, high levels of these molecules can be deleterious to the host itself. Despite their importance, the mechanisms modulating macrophage effector functions are poorly understood. This work introduces two key negative regulators that control the levels and duration of macrophage cytokine production. Vacuolar-type H+-ATPase (V-ATPase) and calcineurin (Cn) constitutively act in normal macrophages to suppress expression of inflammatory cytokines in the absence of specific activation and to inhibit macrophage cytokine responses induced by bacterial lipopolysaccharide (V-ATPase), interferon gamma (V-ATPase and Cn), and calcium (Ca2+) flux (Cn). Cn and V-ATPase modulate effector gene expression at the mRNA level by inhibiting transcription factor NF-kappaB. This negative regulation by Cn is opposite to its crucial positive role in T cells, where it activates NFAT transcription factor(s) leading to expression of interleukin 2, tumor necrosis factor alpha, and other cytokine genes. The negative effects of V-ATPase and Cn on NF-kappaB-dependent gene expression are not limited to the macrophage lineage, as similar effects have been seen with a murine fibroblast cell line and with primary astrocytes.

Citing Articles

Unlocking the therapeutic potential of the NFAT pathway in kidney diseases.

Shreya S, Dagar N, Gaikwad A Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40088333 DOI: 10.1007/s00210-025-04033-x.


TM4SF19-mediated control of lysosomal activity in macrophages contributes to obesity-induced inflammation and metabolic dysfunction.

Choi C, Jeong Y, Park K, Kim M, Kim S, Jo H Nat Commun. 2024; 15(1):2779.

PMID: 38555350 PMC: 10981689. DOI: 10.1038/s41467-024-47108-8.


Central carbon flux controls growth/damage balance for Streptococcus pyogenes.

Merriman J, Xu W, Caparon M PLoS Pathog. 2023; 19(6):e1011481.

PMID: 37384800 PMC: 10337930. DOI: 10.1371/journal.ppat.1011481.


Astrocytic Glutamatergic Transmission and Its Implications in Neurodegenerative Disorders.

Satarker S, Bojja S, Gurram P, Mudgal J, Arora D, Nampoothiri M Cells. 2022; 11(7).

PMID: 35406702 PMC: 8997779. DOI: 10.3390/cells11071139.


(Pro)renin Receptor Inhibition Reduces Plasma Cholesterol and Triglycerides but Does Not Attenuate Atherosclerosis in Atherosclerotic Mice.

Ye D, Yang X, Ren L, Lu H, Sun Y, Lin H Front Cardiovasc Med. 2022; 8:725203.

PMID: 35004870 PMC: 8739895. DOI: 10.3389/fcvm.2021.725203.


References
1.
Huang D, Prystowsky M . Identification of an essential cis-element near the transcription start site for transcriptional activation of the proliferating cell nuclear antigen gene. J Biol Chem. 1996; 271(2):1218-25. DOI: 10.1074/jbc.271.2.1218. View

2.
Hashimoto Y, Perrino B, Soderling T . Identification of an autoinhibitory domain in calcineurin. J Biol Chem. 1990; 265(4):1924-7. View

3.
Remick D . Applied molecular biology of sepsis. J Crit Care. 1995; 10(4):198-212. DOI: 10.1016/0883-9441(95)90011-x. View

4.
Muraoka K, Fujimoto K, Sun X, Yoshioka K, Shimizu K, Yagi M . Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-kappa(B). Implications for FK506 nephropathy. J Clin Invest. 1996; 97(11):2433-9. PMC: 507328. DOI: 10.1172/JCI118690. View

5.
Link E, Kerr L, Schreck R, Zabel U, Verma I, Baeuerle P . Purified I kappa B-beta is inactivated upon dephosphorylation. J Biol Chem. 1992; 267(1):239-46. View